| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7649b77c98cdca3647fe825abf0b4402 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2005-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8c7cf091724736c1112967dbbbe89a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_621bc11f8b87866fc1394cbc07c3ed5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fefadcfff44c86076c4f4a7300fa5bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c920272512b2039427a2b32c3111c4af |
| publicationDate |
2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-548302-A |
| titleOfInvention |
Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases |
| abstract |
Disclosed is a use of a combination of R,R-glycopyrrolate or one of its physiologically acceptable salts and a long-acting beta 2-mimetic agent selected from the group comprising formoterol and salmeterol or a physiologically acceptable salt thereof for the production of a medicament for the treatment of asthma or COPD.Also disclosed is a process of production of the medicament incorporating the said combination. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-4369-C1 |
| priorityDate |
2004-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |